Overview

A Study of GS3-007a for Oral Suspension in the Diagnosis of Adult Growth Hormone Deficiency (AGHD)

Status:
NOT_YET_RECRUITING
Trial end date:
2026-06-09
Target enrollment:
Participant gender:
Summary
The GS3-007a Growth Hormone Stimulation Test (GHST) will be compared with the Insulin Tolerance Test (ITT) in an open-label, randomized, three-way crossover trial. The trial will include subjects suspected to have adult growth hormone deficiency (AGHD) and a group of healthy control subjects.
Phase:
PHASE2
Details
Lead Sponsor:
Changchun GeneScience Pharmaceutical Co., Ltd.
Treatments:
Insulin